Inhibitors of several signal transduction pathways under study at AstraZeneca for cancer, etc. April 6, 2000
Ro-31-7453: extensive preclinical and early clinical data presented this week to the AACR April 5, 2000
Promising flavonoid discovered by Dutch investigators for preventing doxorubicin cardiotoxicity April 5, 2000
WP-769: a doxorubicin analogue that combines oral activity and enhanced effect against topo II April 5, 2000